Clinical Trial Update: Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial assessing autologous bone marrow aspirate concentrate for no-option critical limb ischemia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Lower Limb Ischemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Autologous Bone Marrow Aspirate Concentrate

Snippet

Sponsor: University Hospital Ostrava | Conditions: Critical Lower Limb Ischemia, Type-2 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED